RNXT (RenovoRx, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
RenovoRx, Inc. Common Stock (RNXT) is a publicly traded Healthcare sector company. As of May 19, 2026, RNXT trades at $0.80 with a market cap of $36.98M and a P/E ratio of -2.38. RNXT moved -0.26% today. Year to date, RNXT is -6.23%; over the trailing twelve months it is -33.63%. Its 52-week range spans $0.70 to $1.69. Analyst consensus is strong buy with an average price target of $6.88. Rallies surfaces RNXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns RNXT stock?
Hedge funds tracked by Rallies that own RNXT include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for RenovoRx, Inc. Common Stock.
RNXT Key Metrics
Key financial metrics for RNXT
Metric
Value
Price
$0.80
Market Cap
$36.98M
P/E Ratio
-2.38
EPS
$-0.33
Dividend Yield
0.00%
52-Week High
$1.69
52-Week Low
$0.70
Volume
242.41K
Avg Volume
0
Revenue (TTM)
$1.58M
Net Income
$-12.27M
Gross Margin
74.04%
Top Hedge Funds Holding RNXT
Renaissance Technologies holds 64.90K shares of RNXT, changed +549.00% as of Dec 31, 2024.
Citadel Advisors holds 37.76K shares of RNXT, changed +44.14% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own RNXT include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for RenovoRx, Inc. Common Stock.
Does Rallies show 13F holders for RNXT?
Yes. Rallies tracks hedge fund and 13F ownership data for RNXT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RNXT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RNXT. It does not provide personalized investment advice.
